trending Market Intelligence /marketintelligence/en/news-insights/trending/BfPwYJL0470Yv6kKqMC6KA2 content esgSubNav
In This List

Intellipharmaceutics receives US, Canadian patents for overdose prevention tech

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Intellipharmaceutics receives US, Canadian patents for overdose prevention tech

Intellipharmaceutics International Inc. received patents from the U.S. Patent and Trademark Office and the Canadian Intellectual Property Office for its overdose prevention technology.

The patents cover aspects of Intellipharmaceutics International's Paradoxical OverDose Resistance Activating System delivery technology, designed to prevent overdose when more pills than prescribed are swallowed intact.

The company plans to incorporate its technology in an alternative product candidate for Rexista, its abuse-deterrent oxycodone hydrochloride extended release tablets that are pending approval from the U.S. FDA.